<DOC>
	<DOC>NCT00419666</DOC>
	<brief_summary>This is an open-label, multicenter study to assess the systemic exposure to calcitriol in the adolescent population. Calcitriol 3µg/g ointment (2 mg/cm² per application) is to be applied twice daily to involved skin (10 - 35% BSA involved, excluding face, scalp and intertriginous areas) for 56 days (8 weeks). Full Pharmacokinetic (PK) and Pharmacodynamic (PD) profile will be collected during the first 3 weeks of the study; safety and efficacy data will be collected for the 8 weeks of the treatment.</brief_summary>
	<brief_title>A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Diagnosis of chronic plaque psoriasis 10 35% BSA of involved skin Age 12 17 Other type of psoriasis (other than plaque) Significant abnormal lab findings Vit D insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Calcitriol</keyword>
	<keyword>Psoriasis</keyword>
	<keyword>PK</keyword>
	<keyword>Adolescents</keyword>
</DOC>